3-methoxytyramine has been researched along with Liver Cirrhosis in 1 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergeron, M | 1 |
| Reader, TA | 1 |
| Layrargues, GP | 1 |
| Butterworth, RF | 1 |
1 other study available for 3-methoxytyramine and Liver Cirrhosis
| Article | Year |
|---|---|
Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
Topics: Aged; Biogenic Monoamines; Brain; Caudate Nucleus; Cerebral Cortex; Chromatography, High Pressure Li | 1989 |